SCHEMBL32670901

SCHEMBL32670901

CC(=O)Oc1c(C)c(C)c2ccccc2c1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.54
HTT P42858 3/20 0.54
HSD17B10 Q99714 3/20 0.54
MAPT P10636 3/20 0.54
TP53 P04637 1/20 0.54
GAA P10253 1/20 0.54
ALDH1A1 P00352 4/20 0.44
HPGD P15428 2/20 0.44
BACE1 P56817 1/20 0.43
SLC22A6 Q4U2R8 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
LMNA P02545 2/20 0.41
MAPK1 P28482 1/20 0.41
GSK3B P49841 1/20 0.41
ADK P55263 1/20 0.41
TSHR P16473 2/20 0.40
ELANE P08246 1/20 0.40
ESR1 P03372 1/20 0.40
ITGB3 P05106 1/20 0.40
ITGA2B P08514 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4186404 0.90 KDM4E (0.57) KDM4EHTTHSD17B10MAPTTP53
SCHEMBL13666895 0.88 KDM4E (0.62) KDM4EHTTHSD17B10MAPTTP53
SCHEMBL29368738 0.81 KDM4E (0.63) KDM4EHTTHSD17B10MAPTTP53
SCHEMBL6907648 0.81 KDM4E (0.63) KDM4EHTTHSD17B10MAPTTP53
SCHEMBL31117559 0.80 KDM4E (0.50) KDM4EHTTHSD17B10MAPTTP53
SCHEMBL9358599 0.80 KDM4E (0.50) KDM4EHTTHSD17B10MAPTTP53
SCHEMBL9713872 0.80 KDM4E (0.59) KDM4EHTTHSD17B10MAPTTP53
SCHEMBL9507056 0.80 LMNA (0.44) KDM4EHTTHSD17B10MAPTTP53
SCHEMBL11780453 0.79 KDM4E (0.61) KDM4EHTTHSD17B10MAPTTP53
SCHEMBL13134484 0.78 LMNA (0.42) KDM4EHTTHSD17B10MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12544730-B2 Process for preparing microcapsules FIRMENICH SA (CH) 2026-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12544730-B2 Process for preparing microcapsules ALB, S100A9, S100P KDM4E 3920/4885HTT 1211/4885HSD17B10 3581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.